Struggling for supply

Shortage notice issued for multiple presentations of arthritis treatment The Therapeutic Goods Administration (TGA) has issued a warning regarding shortages of multiple presentations of tocilizumab (Actemra). Roche, the sponsor of tocilizumab (Actemra), notified the TGA on 21 July, saying the shortage was due to global demand in response to the COVID-19 pandemic. In its notice,